SCHEMBL8312348

SCHEMBL8312348

CC(C)NC(=O)CN1CCN(C(=O)c2ccc(Nc3nccc(-c4ccc(S(=O)(=O)C5CCOCC5)cc4)n3)cc2)CC1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MTOR P42345 1/20 0.48
SMG1 Q96Q15 1/20 0.48
MYLK4 Q86YV6 1/20 0.45
STK17A Q9UEE5 1/20 0.45
JAK2 O60674 16/20 0.45
JAK3 P52333 12/20 0.45
JAK1 P23458 5/20 0.45
TYK2 P29597 2/20 0.44
HDAC1 Q13547 2/20 0.44
HDAC3 O15379 1/20 0.44
NCOR1 O75376 1/20 0.44
HDAC2 Q92769 1/20 0.44
HDAC8 Q9BY41 1/20 0.44
HDAC6 Q9UBN7 1/20 0.44
CDK2 P24941 2/20 0.44
BMPR1B O00238 1/20 0.44
PLK4 O00444 1/20 0.44
CIT O14578 1/20 0.44
GAK O14976 1/20 0.44
OPA1 O60313 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8312166 0.88 IKBKB (0.54) MTORSMG1MYLK4STK17AJAK2
SCHEMBL13590786 0.86 IKBKB (0.51) MTORSMG1JAK2JAK3JAK1
SCHEMBL14021585 0.85 CDK1 (0.53) MTORSMG1MYLK4STK17AJAK2
SCHEMBL4071263 0.84 SYK (0.47) MTORSMG1JAK2JAK3JAK1
SCHEMBL8313895 0.84 JAK2 (0.54) MTORSMG1JAK2JAK3JAK1
SCHEMBL14021396 0.83 IKBKB (0.56) MTORSMG1JAK2JAK3JAK1
SCHEMBL8312451 0.83 IKBKB (0.58) MTORSMG1JAK2JAK3JAK1
SCHEMBL14021233 0.83 CDK1 (0.49) MTORSMG1MYLK4STK17AJAK2
SCHEMBL8312206 0.82 MTOR (0.50) MTORSMG1JAK2JAK3JAK1
SCHEMBL8313348 0.81 SMG1 (0.48) MTORSMG1JAK2JAK3JAK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7442699-B2 Anilinopyrimidine derivatives as IKK inhibitors and compositions and methods related thereto SIGNAL PHARMACEUTICALS, LLC (US) 2008-10-28 US disclosed
US-7442699-B2 Anilinopyrimidine derivatives as IKK inhibitors and compositions and methods related thereto SIGNAL PHARMACEUTICALS, LLC (US) 2008-10-28 US disclosed
US-7429599-B2 Methods for treating or preventing an inflammatory or metabolic condition or inhibiting JNK SIGNAL PHARMACEUTICALS, LLC (US) 2008-09-30 US disclosed
US-7429599-B2 Methods for treating or preventing an inflammatory or metabolic condition or inhibiting JNK SIGNAL PHARMACEUTICALS, LLC (US) 2008-09-30 US disclosed
WO-2004084901-A1 METHODS FOR TREATING OR PREVENTING AN INFLAMMATORY OR METABOLIC CONDITION BY INHIBITING JNK SIGNAL PHARMACEUTICALS, LLC (US) 2004-10-07 WO disclosed